Multiply Labs, a San Francisco-based robotics company, announced an expansion of its collaboration with Thermo Fisher Scientific. The enhanced partnership will integrate Thermo Fisher's Gibco™ CTS™ DynaCellect™ Magnetic Separation System with Multiply Labs' robotic platforms.
The Gibco™ CTS™ DynaCellect™ System is a closed, automated isolation, activation and bead removal system for cell therapy development and manufacturing. Combining this system with Multiply Labs' robotic automation will accelerate critical manufacturing steps by reducing manual intervention and improving process consistency.
"Our expanded collaboration with Multiply Labs will enable customers to achieve end-to-end automation in their manufacturing processes."
Andy Campbell, Senior Director of R&D, Thermo Fisher Scientific
Multiply Labs' robotic systems are designed to automate complex biomanufacturing workflows, enabling high-throughput, flexible production of cell therapies.
"This extended partnership is another step toward fully autonomous cell therapy manufacturing, reducing costs, minimizing human error, and ultimately getting treatments to patients faster."
Fred Parietti, PhD, Co-Founder & CEO, Multiply Labs
The collaboration builds on existing work automating cell expansion and separation processes, including the Heracell™ VIOS Automated Access CO₂ Incubator and the Gibco™ CTS™ Rotea™ Counterflow Centrifugation System.